In peripheral blood, plasmablasts also displayed a higher RUNX1 levels in MM patients (398 ± 31) compared to controls (286 ± 17), though the difference did not reach statistical significance (P = 0.1441) (Figure 3B). Here, RUNX1 is linked to Miyoshi myopathy.